Company intelligence / Profile preview

Gravitas Medical

San Francisco, California, United Statesgravitasmedinc.com ↗

Ownership: Private
Development stage: Commercial

Overview

The Entarik Platform by Gravitas Medical has received FDA clearance for its enteral feeding intelligence system. Clinical studies demonstrated 100% accuracy in nasogastric tube placement using the Entarik device as a guide. The platform leverages embedded sensors to collect real-time gastrointestinal data to improve patient safety and outcomes during enteral nutrition delivery. It has also received two FDA Breakthrough Device Designations to accelerate development for pediatric use.

Therapeutic areas: GastroenterologyOther
Modalities: DeviceSensor-based platform
Industry: Physiological Monitoring

Partnerships

MedTech InnovatorUCSF-Stanford Pediatric Device Consortium

Beyond the preview

Go deeper on Gravitas Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gravitas Medical.

Explore the full profile